Results 51 to 60 of about 4,787,434 (307)
Acute respiratory failure in COVID-19: is it “typical” ARDS?
In December 2019, an outbreak of coronavirus disease 2019 (COVID-19) was identified in Wuhan, China. The World Health Organization (WHO) declared this outbreak a significant threat to international health.
Xu Li, Xiaochun Ma
semanticscholar +1 more source
Background The information needs of patients and their families regarding interstitial lung disease (ILD) have yet to be studied in detail, and few reports have examined the differences in information needs according to patient status.
Ryuhei Sato +3 more
doaj +1 more source
Liver histopathology in severe COVID 19 respiratory failure is suggestive of vascular alterations
SARS2‐CoV‐2 breakout in Italy caused a huge number of severely ill patients with a serious increase in mortality. Although lungs seem to be the main target of the infection, very few information are available about liver involvement, possibly evocating a
A. Sonzogni +12 more
semanticscholar +1 more source
Hypovitaminosis D is a highly spread condition correlated with increased risk of respiratory tract infections. Nowadays, the world is in the grip of the Coronavirus disease 19 (COVID 19) pandemic.
G. E. Carpagnano +9 more
semanticscholar +1 more source
Highlights • COVID19 patients can develop severe acute respiratory distress syndrome (ARDS).• ARDS is a fatal complication and the most common cause of death in COVID19 patients.• Early detection of acute respiratory failure is mandatory to promplty ...
Erika Poggiali +12 more
semanticscholar +1 more source
Our understanding of the protective immunity, particularly the long-term dynamics of neutralizing antibody (NAbs) response to SARS-CoV-2, is currently limited.
Xin Xu +13 more
doaj +1 more source
Airway bacterial and fungal microbiome in chronic obstructive pulmonary disease
Little is known about airway mycobiome, and its relationship with bacterial microbiome in chronic obstructive pulmonary disease (COPD). Here we report the first simultaneous characterization of sputum bacterial and fungal microbiome in 84 stable COPD and
Haiyue Liu +14 more
doaj +1 more source
ABSTRACT Background Secretory phospholipase A2 (sPLA2) is an inflammatory mediator linked to acute chest syndrome (ACS) in sickle cell disease (SCD), a serious complication that can develop during an acute vaso‐occlusive pain episode (VOE). Plasma sPLA2 levels have been proposed as a potential biomarker for predicting ACS onset.
Rawan Korman +10 more
wiley +1 more source
Congenital central hypoventilation syndrome (CCHS) is a rare disorder characterised by autonomic dysfunction and typically presents in infancy, although adult‐onset disease is increasingly recognised. We report a genetically confirmed case of adult‐onset
Sushil Agwan +2 more
doaj +1 more source
ABSTRACT Background Therapeutic apheresis (TA) is an established treatment modality for hematologic, neurologic, and immunologic disorders, yet access remains severely limited in sub‐Saharan Africa. Donor apheresis, including platelet apheresis collection from healthy donors, represents an important complementary modality supporting blood product ...
Nosa Bazuaye +33 more
wiley +1 more source

